DeutschNewstral
Article
Mmarketwatch.com on 2019-06-17 13:53
Orgenesis shares soar 19% premarket after FDA grants orphan designation to insulin tech
Related news
- MAkari Therapeutics shares soar 13% premarket after FDA grants Orphan Drug designation to nomacopanmarketwatch.com
- MNovavax shares soar 20% premarket after company wins FDA fast-track designation for flu vaccinemarketwatch.com
- MUPDATE: Pluristem stock jumps 21% premarket after FDA grants CLI treatment fast-track designationmarketwatch.com
SA biotech gets FDA orphan drug designationbizjournals.com
Sapience Therapeutics ST-36 receives orphan drug designation from FDAwestfaironline.com- MProQR shares rises on FDA orphan drug designationmarketwatch.com
- MCerecor stock soars 17% premarket after FDA grants fast-track designation to treatment for rare disordermarketwatch.com
- Imbrium Therapeutics receives FDA orphan drug designation for biliary tract cancer drugwestfaironline.com
FDA Issues Draft Guidance on Orphan Drug Designation in Pediatric Subpopulationsjdsupra.com- Philadelphia gene therapy company gets FDA Orphan Drug Designation for lead product candidatebizjournals.com
- MSeres shares drop 7% after news of FDA orphan drug designation for ulcerative colitis therapymarketwatch.com
- MClovis Oncology stock rises 10% premarket after 'breakthrough' designation from FDAmarketwatch.com
- MAntares Pharma, Amag Pharma shares soar premarket after FDA approves auto injectormarketwatch.com
- MAvadel Pharma shares soar 22% premarket after FDA cuts sample size in trial of narcolepsy treatmentmarketwatch.com
- MPluristem shares jump 5.4% premarket as FDA approves trial of treatment for critical limb ischemiamarketwatch.com
Lundbeck's Carnexiv gets FDA orphan drug statusdailyherald.com
Orphan drugs for rare diseases soarBoston Herald- FDA Clarifies Premarket Path for Ecigarette Productsjdsupra.com
FDA approves upgraded insulin delivery systemidahobusinessreview.com
FDA Approves Medtronic’s New Automated Insulin Pumpwsj.com